Systematic review estimates sputum culture conversion time in drug-resistant tuberculosis patients, indicating key predictors.
BACKGROUND: Drug-resistant tuberculosis remains a major public health challenge in Ethiopia. Delayed sputum culture conversion prolongs infectiousness and worsens treatment outcomes, yet evidence on its timing and predictors is inconsistent. OBJECTIVE: To estimate the pooled time to sputum culture conversion and identify its predictors among drug-resistant tuberculosis patients in Ethiopia. METHODS: A systematic search of PubMed, Google Scholar, Embase, Scopus, Web of Science, and Ethiopian university repositories was conducted for studies published between January 2000 and March 2026. Data were analyzed using R (version 4.4.2) and Stata/MP 17. Heterogeneity and publication bias were assessed. Subgroup analyses and sensitivity analysis explored sources of variation. RESULTS: Eleven retrospective cohort studies with 2,851 patients were included. The pooled median time to sputum culture conversion was 68.92 days (IQR: 57.64-80.19; I²=99.87%). Delayed conversion was associated with previous anti-tuberculosis treatment (aHR=0.46; 95% CI: 0.33-0.64), smear grades (+2: aHR=0.42; 95% CI: 0.26-0.68, and +3: aHR=0.42; 95% CI: 0.29-0.61), underweight status (aHR=0.75; 95% CI: 0.65-0.84), and lung cavitation (aHR = 0.48; 95% CI: 0.33-0.69). CONCLUSION: Culture conversion occurs at approximately two months. Identified risk factors highlight the need for early risk stratification, nutritional support, and close monitoring to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Eshetu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: